🇪🇺 Benzodiazepine Addiction Treatment · Latvia

Benzodiazepines are prescribed for anxiety and insomnia, but long-term use can lead to physical dependence and addiction. In Latvia, as across Europe, misuse of these medications is a growing concern. At European Addiction Centers (EAC), we connect you with accredited partner clinics across Latvia that specialise in benzodiazepine addiction treatment. Our network ensures you receive evidence-based, medically supervised care tailored to your needs. According to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), benzodiazepines are the most commonly misused prescription drugs in the EU. For comprehensive information on treatment approaches, read our page on Benzodiazepine Addiction Treatment.

Latvia faces a significant challenge with benzodiazepine misuse. According to the European Drug Report 2023, Latvia reported one of the highest rates of high-risk prescription drug use in the EU, with benzodiazepines accounting for nearly 60% of all drug-related emergency department visits in Riga. The Latvian Centre for Disease Prevention and Control noted that in 2022, over 12% of adults seeking help for substance use disorders listed benzodiazepines as their primary substance. Legally, Latvia follows a public health-oriented approach, with possession for personal use being a minor offence, but treatment is strongly encouraged over punishment. Culturally, stigma around addiction remains high, particularly in rural areas like Daugavpils and Liepāja, which can delay people seeking help. However, private clinics in Riga and Jūrmala are increasingly offering confidential, discreet care. For a list of accredited facilities, visit our page on rehab centres in Latvia. The trend towards medicalisation of addiction in Latvia is slowly reducing barriers to care.

Benzodiazepine addiction can develop even when taken as prescribed. Physical signs include drowsiness, slurred speech, and poor coordination, while psychological symptoms involve memory problems, irritability, and intense cravings. Withdrawal can be dangerous, leading to seizures or panic attacks. Co-occurring mental health conditions, such as anxiety disorders or depression, are common and require dual diagnosis treatment. The impact on family and work is profound: relationships often suffer due to mood swings, and job performance declines with cognitive impairment. Many individuals in Latvia report feeling isolated, as the condition is often hidden due to stigma. Seeking professional help is the safest path to recovery.

EAC connects you with partner clinics across Latvia offering a range of treatment options for benzodiazepine addiction. These include medically supervised detoxification, residential programmes, day programmes, and outpatient support. Evidence-based therapies used include Cognitive Behavioural Therapy (CBT) to address underlying thought patterns, Dialectical Behaviour Therapy (DBT) for emotional regulation, and Medication-Assisted Treatment (MAT) for managing withdrawal. Some clinics also offer EMDR for trauma-related cases. All partner clinics are accredited, maintain multilingual staff (Latvian, Russian, English), and operate under strict GDPR-compliant confidentiality. Treatment is private, meaning no waiting lists and immediate admission. Whether you are in Riga or elsewhere in Latvia, EAC ensures you are placed in a clinic suited to your clinical and personal needs. Each programme is designed to address the specific challenges of benzodiazepine dependence.

EAC connects you with partner clinics across Latvia offering a range of treatment options for benzodiazepine addiction. These include medically supervised detoxification, residential programmes, day programmes, and outpatient support. Evidence-based therapies used include Cognitive Behavioural Therapy (CBT) to address underlying thought patterns, Dialectical Behaviour Therapy (DBT) for emotional regulation, and Medication-Assisted Treatment (MAT) for managing withdrawal. Some clinics also offer EMDR for trauma-related cases. All partner clinics are accredited, maintain multilingual staff (Latvian, Russian, English), and operate under strict GDPR-compliant confidentiality. Treatment is private, meaning no waiting lists and immediate admission. Whether you are in Riga or elsewhere in Latvia, EAC ensures you are placed in a clinic suited to your clinical and personal needs. Each programme is designed to address the specific challenges of benzodiazepine dependence.

The process at EAC partner clinics is clear and structured:

This structured pathway ensures continuity of care from the first call to long-term recovery.

1. 1. Free confidential assessment – Contact us by phone or online form. A specialist will discuss your situation within 24 hours, often the same day.
2. 2. Personalised treatment plan – A clinical team designs a plan tailored to your addiction severity, dual diagnoses, and personal circumstances.
3. 3. Placement and admission – We match you with an accredited partner clinic in Latvia, and you are admitted within days.
4. 4. Treatment programme – Typical duration is 4–12 weeks, including detox, therapy, and skill-building sessions.
5. 5. Aftercare and relapse prevention – A comprehensive plan is created before discharge, including ongoing therapy and support groups.

Choosing EAC means accessing a network dedicated to your recovery, with no administrative delays and full transparency.